Viewing Study NCT07108868

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 6:26 PM
Ignite Modification Date: 2025-12-30 @ 6:28 AM
Study NCT ID: NCT07108868
Status: RECRUITING
Last Update Posted: 2025-08-07
First Post: 2025-07-24
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: A Phase I Dose Finding Study of MB-CART2219.1
Sponsor: University Hospital Tuebingen
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Lymphoma View
None CLL View
None Acute Lymphoblastic Leukemia, Pediatric View
Keywords:

Keywords

Keyword Brief Keyword Text View
None MB-CART2219.1 targeting CD19/CD22 View
None CD19/CD22 View
None CAR-T cells View